2671 篇
1100 篇
195094 篇
3402 篇
6327 篇
2249 篇
2818 篇
539 篇
29830 篇
10185 篇
3209 篇
773 篇
2312 篇
1328 篇
451 篇
753 篇
1392 篇
2639 篇
2751 篇
4083 篇
全球肝细胞癌治疗市场预测流行病学管道分析(2022-2027年)
Global Hepatocellular Carcinoma Treatment Market Forecast - Epidemiology Pipeline Analysis 2022-2027
Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer. Hepatocellular carcinoma constitutes more than 90% of the primary tumor of the liver. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection, accounting for ~50% of cases.
CHAPTER – 1: HEPATOCELLULAR CARCINOMA OVERVIEW
CHAPTER – 2: HEPATOCELLULAR CARCINOMA EPIDEMIOLOGY & OVERVIEW
CHAPTER - 3: HEPATOCELLULAR CARCINOMA MARKET SIZE & OVERVIEW
CHAPTER – 4: HEPATOCELLULAR CARCINOMA MARKETED DRUGS OVERVIEW
CHAPTER – 5: HEPATOCELLULAR CARCINOMA PIPELINE DRUGS OVERVIEW